NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 2 hours 56 min ago

Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional)

Thu, 2023-10-05 13:12
Funding Opportunity PAR-23-308 from the NIH Guide for Grants and Contracts. This funding opportunity seeks to support the Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) Program. The CPACHE Program develops and maintains comprehensive, long-term, and mutually beneficial partnerships between institutions serving underserved health disparity populations and underrepresented students (ISUPSs) and NCI-designated Cancer Centers (CCs). The program aims to achieve a stronger national cancer program and address challenges in cancer and cancer disparities research, education, and outreach, as well as cancer's impact on underserved populations. The institutions in each partnership are expected to work collaboratively to: (1) increase the cancer research and cancer research education capacity of the ISUPSs; (2) promote the diversity of the cancer research workforce; (3) improve the effectiveness of CCs in developing and sustaining research programs focused on cancer health disparities and increase the number of investigators and students conducting cancer health disparities research; and (4) develop and implement cancer-related outreach and education initiatives that benefit the surrounding underserved communities.

National Institute of General Medical Sciences Predoctoral Basic Biomedical Sciences Research Training Program (T32)

Thu, 2023-10-05 06:21
Funding Opportunity PAR-23-228 from the NIH Guide for Grants and Contracts. The goal of the NIGMS Predoctoral Basic Biomedical Sciences Research Training Program is to develop a diverse pool of well-trained scientists available to address the Nations biomedical research agenda. Specifically, this funding opportunity announcement provides support to eligible, domestic institutions to develop and implement effective, evidence-informed approaches to biomedical graduate training and mentoring that will keep pace with the rapid evolution of the biomedical research enterprise. NIGMS expects that the proposed research training programs will incorporate didactic, research, and career development elements to prepare trainees for careers that will have a significant impact on the health-related research needs of the Nation.

Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R01 Clinical Trial Not Allowed)

Thu, 2023-10-05 06:11
Funding Opportunity RFA-DA-25-011 from the NIH Guide for Grants and Contracts. This broad RFA will support exploratory studies addressing mechanistic questions in HIV infection, replication, latency, and/or pathogenesis (including HAND) in the context of SUDs.

Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Basic Experimental Studies with Humans Required)

Thu, 2023-10-05 05:38
Funding Opportunity RFA-DA-24-034 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to encourage clinical research that will identify and validate novel targets for non-invasive brain stimulation (NIBS) and SUD-relevant neurobiological, cognitive, and behavioral responses to NIBS that precede clinical outcomes like reduced craving or drug use. Applications are expected to be exploratory and developmental in nature. As such, these studies may involve considerable risk of failure but may lead to a breakthrough in a particular area that could have a major impact on SUD research involving NIBS. This NOFO uses a R61/R33 Phased Innovation award activity code to support applications that propose mechanistic studies designed to understand a behavior or biological process, the pathophysiology of a disease, or the mechanism of action of an intervention. In addition, applications must meet the NIH definition of a clinical trial. NIH defines a clinical trial as A research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes. (NOT-OD-15-015)

HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)

Wed, 2023-10-04 12:01
Funding Opportunity PAR-24-037 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to support multi-component, multi-disciplinary projects that address scientific questions relevant to AIDS prophylactic vaccine discovery research. Extensive evaluation of vaccine concepts in non-human primate models may be included.

R25 for Short Courses on Techniques for Measuring Intimate Partner Violence (IPV) in Different Populations (R25 Clinical Trial Not Allowed)

Wed, 2023-10-04 11:49
Funding Opportunity RFA-OD-24-002 from the NIH Guide for Grants and Contracts. To advance the goals of the NIH Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE) Initiative, this NIH R25 Short Course Award solicits applications for short courses focusing on educating researchers on best practices for screening and/or measuring IPV in populations impacted by maternal mortality. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this NIH R25 program is to support educational activities that foster a better understanding of biomedical, behavioral and clinical research and its implications. To accomplish the stated over-arching goal, this NOFO will support educational activities with a primary focus on Courses for Skills.

Request for Information (RFI): Environmental Justice Research Gaps, Opportunities and Capacity Building

Wed, 2023-10-04 11:39
Notice NOT-ES-23-016 from the NIH Guide for Grants and Contracts

Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional)

Wed, 2023-10-04 03:07
Funding Opportunity RFA-DA-25-059 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support the testing of enhanced models of care that optimally integrate HIV, addiction, and primary care services.

NIH Operates Under a Continuing Resolution

Wed, 2023-10-04 02:55
Notice NOT-OD-24-007 from the NIH Guide for Grants and Contracts

Single Source: Human Tumor Atlas Network Data Coordinating Center (HTAN-DCC; U24 Clinical Trial Not Allowed)

Tue, 2023-10-03 12:12
Funding Opportunity RFA-CA-23-041 from the NIH Guide for Grants and Contracts. Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to accelerate sharing of complex single-cell level data with the cancer research community. The Human Tumor Atlas Network Data Coordinating Center (HTAN-DCC) will serve the dual role of network and data coordination. Administratively the HTAN-DCC will be responsible for meeting coordination, including planning and administration of monthly HTAN Steering Committee meetings, monthly HTAN working group meetings, and semi-annual HTAN face-to-face meetings. A focus on HTAN data and tool reusability through the development and deployment of community education resources will outweigh the need for creating additional data sharing infrastructure in the renewal period. Additionally, it is expected that the HTAN-DCC will remain a testbed for important interactions with the NCI Cancer Research Data Commons (CRDC) and will further drive development of CRDC resources required for sharing, interacting with, and integrating across highly multiplexed imaging datasets. The HTAN-DCC will also work closely with the CRDC to ensure all relevant data and metadata is transferred to the CRDC for long-term data sustainability. Just as they did in the first phase of HTAN, these important interactions will benefit a wide scientific community and have the potential to synergize with other NCI and NIH supported programs. A reduced budget request for the HTAN-DCC reflects reuse of infrastructure developed within the first phase of HTAN, while acknowledging that a significant number of nimble and responsive HTAN-DCC personnel are required for data wrangling, ingest, and sharing.

Career Enhancement Award to Advance the Study of Intimate Partner Violence (IPV) in the Context of Maternal Morbidity and Mortality Research (K18 Clinical Trial Not Allowed)

Tue, 2023-10-03 11:56
Funding Opportunity RFA-OD-24-001 from the NIH Guide for Grants and Contracts. To advance the goals of the NIH Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE) Initiative, this NIH Research Career Enhancement Award (K18) invites applications from experienced investigators in maternal morbidity and mortality research seeking to expand their research programs through the acquisition of new skills and knowledge in the area of intimate partner (and related) violence (IPV). The program will support research training and career development experiences and a small-scale research project that will provide experienced investigators with the scientific competencies required to integrate IPV and related violence constructs, theories, and/or interventions into their ongoing research efforts. Eligible candidates are independent investigators at any faculty rank or level.

Notice of Special Interest (NOSI): The Road to Prevention of Stillbirth

Tue, 2023-10-03 04:52
Notice NOT-HD-23-021 from the NIH Guide for Grants and Contracts

Pages